Metabolex, Inc.
44Patents
23Active
44Granted
44Portfolio score
Filing activity: Sep 2, 1994 → Oct 5, 2012 · 19 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6613802B1 | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia | Human Necessities | 70 | Expired |
| US7638541B2 | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine | Chemistry; Metallurgy | 33 | Active |
| US6020200A | Encapsulation compositions and methods | Emerging Cross-Sectional Technologies | 30 | Expired |
| US6624194B1 | Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia | Chemistry; Metallurgy | 20 | Expired |
| US6262118A | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia | Human Necessities | 19 | Expired |
| US5693514A | Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6646004B1 | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia | Human Necessities | 15 | Expired |
| US8476308B2 | GPR120 receptor agonists and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US5738876A | Method of solution overcoating with gelling polymer | Chemistry; Metallurgy | 12 | Expired |
| US5916790A | Encapsulation compositions, and methods | Emerging Cross-Sectional Technologies | 11 | Expired |
| US8183381B2 | N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 11 | Active |
| US7199259B2 | Resolution of α-(phenoxy)phenylacetic acid derivatives | Chemistry; Metallurgy | 10 | Expired |
| US8227495B2 | 2,4-disubsituted thiazoles and pharmaceutical compositions thereof | Chemistry; Metallurgy | 10 | Active |
| US7576131B2 | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia | Chemistry; Metallurgy | 8 | Expired |
| US8288384B2 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 7 | Active |
| US8410127B2 | Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts | Chemistry; Metallurgy | 7 | Active |
| US7053180B2 | Isolated islet beta-cell two-pore domain potassium channel | Physics | 7 | Expired |
| US7714131B2 | Process for the stereoselective preparation of (−)-halofenate and derivatives thereof | Chemistry; Metallurgy | 6 | Active |
| US7087394B2 | Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP | Physics | 6 | Expired |
| US7432394B2 | Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines | Chemistry; Metallurgy | 6 | Active |
| US8598374B2 | GPR120 receptor agonists and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US7405289B2 | Pancreatic islet transcription factor and uses thereof | Chemistry; Metallurgy | 4 | Expired |
| US8299117B2 | GPR120 receptor agonists and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US7323480B2 | Substituted triazoles as modulators of PPAR and methods of their preparation | Chemistry; Metallurgy | 3 | Expired |
| US7510851B2 | Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia | Physics | 3 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.